The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients

BACKGROUND: In addition to morphological and cytogenetic features, acute myeloid leukemias are characterized by mutations that can be used for target-therapy; also the minimal/measurable residual disease (MRD) could be an important prognostic factor. The purpose of this retrospective study was to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehzadeh, Serena, Guerrini, Francesca, Pizzano, Umberto, Grassi, Susanna, Ciabatti, Elena, Iovino, Lorenzo, Buda, Gabriele, Caracciolo, Francesco, Benedetti, Edoardo, Orciuolo, Enrico, Pelosini, Matteo, Consani, Giovanni, Carulli, Giovanni, Metelli, Maria Rita, Martini, Francesca, Mazziotta, Francesco, Mazzantini, Elisa, Rossi, Pietro, Tavarozzi, Rita, Ricci, Federica, Petrini, Mario, Galimberti, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449954/
https://www.ncbi.nlm.nih.gov/pubmed/30992690
http://dx.doi.org/10.1186/s12935-019-0807-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449954/
https://www.ncbi.nlm.nih.gov/pubmed/30992690
http://dx.doi.org/10.1186/s12935-019-0807-0

Ejemplares similares